In silico drug design strategies for discovering novel tuberculosis therapeutics

Christian S. Carnero Canales,Aline Renata Pavan,Jean Leandro dos Santos,Fernando Rogério Pavan
DOI: https://doi.org/10.1080/17460441.2024.2319042
2024-02-21
Expert Opinion on Drug Discovery
Abstract:Introduction Tuberculosis remains a significant concern in global public health due to its intricate biology and propensity for developing antibiotic resistance. Discovering new drugs is a protracted and expensive endeavor, often spanning over a decade and incurring costs in the billions. However, computer-aided drug design (CADD) has surfaced as a nimbler and more cost-effective alternative. CADD tools enable us to decipher the interactions between therapeutic targets and novel drugs, making them invaluable in the quest for new tuberculosis treatments.
pharmacology & pharmacy
What problem does this paper attempt to address?